Critical evaluation of drug promotional literature using the WHO guidelines: A hospital-based, cross-sectional, and observational study

Kanathur N Chaithra; Eregodu Manjunath Sparshadeep; Basavaraj Rajesh; Bai G Priyadarshini; Gowthamapura Venkatappa Kavana

doi:10.5455/njppp.2023.13.06332202307072023

2024, Vol: 14, Issue: 9

14 / 9Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research
Online Published: 14 Jul 2023

Natl J Physiol Pharm Pharmacol. 2024; 14(2): 254-258

doi: 10.5455/njppp.2023.13.06332202307072023

Critical evaluation of drug promotional literature using the WHO guidelines: A hospital-based, cross-sectional, and observational study

Kanathur N Chaithra, Eregodu Manjunath Sparshadeep, Basavaraj Rajesh, Bai G Priyadarshini, Gowthamapura Venkatappa Kavana.

Abstract
Background: Drug promotional literatures (DPLs) offered by pharmaceutical companies are crucial tools for promoting their products to prescribers. The printed DPLs distributed by pharmaceutical companies are frequently biased, according to numerous studies.

Aims and Objectives: The study was undertaken with the objective of evaluating the accuracy of the DPL using the World Health Organization (WHO) criteria.

Materials and Methods: A cross-sectional and observational study of 6-month duration was carried out in the outpatient departments of a tertiary care hospital to analyze the DPL of different pharmaceutical companies using the WHO criteria “Ethical criteria for medicinal drug promotion, 1988.” Microsoft Excel was used for the analysis of descriptive statistics.

Results: A total of 246 (75.5%) brochures satisfied more than 50% of the WHO criteria. References to scientific literature 146 (44.8%); efficacy information 60 (18.4%); side effects and major adverse drug reactions (ADRs), precautions, warnings and contraindications, and major drug interaction 76 (23.3%), 54 (16.6%), and 56 (17.2%) respectively; exaggerated claims 112 (34.5%); fixed dose drug combination promotion 221 (67.5%); single DPL with multiple drug promotion 104 (31.9%) were the relevant percentage distribution of various components of the total DPLs analyzed in the study.

Conclusion: The pharmaceutical companies adequately advertise their brand and generic names, and dose and dosage forms but lack the adequacy and accuracy in the safety and efficacy information, and the source of literature in their respective drug promotional materials.

Key words: Advertisement; Drug Promotional Literature; World Health Organization Guidelines; Pharmaceutical Company; Brochure

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Kanathur N Chaithra Articles by Eregodu Manjunath Sparshadeep Articles by Basavaraj Rajesh Articles by Bai G Priyadarshini Articles by Gowthamapura Venkatappa Kavana
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Chaithra KN, Sparshadeep EM, Rajesh B, Priyadarshini BG, Kavana GV. Critical evaluation of drug promotional literature using the WHO guidelines: A hospital-based, cross-sectional, and observational study. Natl J Physiol Pharm Pharmacol. 2024; 14(2): 254-258. doi:10.5455/njppp.2023.13.06332202307072023

Web Style

Chaithra KN, Sparshadeep EM, Rajesh B, Priyadarshini BG, Kavana GV. Critical evaluation of drug promotional literature using the WHO guidelines: A hospital-based, cross-sectional, and observational study. https://www.njppp.com/?mno=159068 [Access: September 12, 2024]. doi:10.5455/njppp.2023.13.06332202307072023

AMA (American Medical Association) Style

Chaithra KN, Sparshadeep EM, Rajesh B, Priyadarshini BG, Kavana GV. Critical evaluation of drug promotional literature using the WHO guidelines: A hospital-based, cross-sectional, and observational study. Natl J Physiol Pharm Pharmacol. 2024; 14(2): 254-258. doi:10.5455/njppp.2023.13.06332202307072023

Vancouver/ICMJE Style

Chaithra KN, Sparshadeep EM, Rajesh B, Priyadarshini BG, Kavana GV. Critical evaluation of drug promotional literature using the WHO guidelines: A hospital-based, cross-sectional, and observational study. Natl J Physiol Pharm Pharmacol. (2024), [cited September 12, 2024]; 14(2): 254-258. doi:10.5455/njppp.2023.13.06332202307072023

Harvard Style

Chaithra, K. N., Sparshadeep, . E. M., Rajesh, . B., Priyadarshini, . B. G. & Kavana, . G. V. (2024) Critical evaluation of drug promotional literature using the WHO guidelines: A hospital-based, cross-sectional, and observational study. Natl J Physiol Pharm Pharmacol, 14 (2), 254-258. doi:10.5455/njppp.2023.13.06332202307072023

Turabian Style

Chaithra, Kanathur N, Eregodu Manjunath Sparshadeep, Basavaraj Rajesh, Bai G Priyadarshini, and Gowthamapura Venkatappa Kavana. 2024. Critical evaluation of drug promotional literature using the WHO guidelines: A hospital-based, cross-sectional, and observational study. National Journal of Physiology, Pharmacy and Pharmacology, 14 (2), 254-258. doi:10.5455/njppp.2023.13.06332202307072023

Chicago Style

Chaithra, Kanathur N, Eregodu Manjunath Sparshadeep, Basavaraj Rajesh, Bai G Priyadarshini, and Gowthamapura Venkatappa Kavana. "Critical evaluation of drug promotional literature using the WHO guidelines: A hospital-based, cross-sectional, and observational study." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 254-258. doi:10.5455/njppp.2023.13.06332202307072023

MLA (The Modern Language Association) Style

Chaithra, Kanathur N, Eregodu Manjunath Sparshadeep, Basavaraj Rajesh, Bai G Priyadarshini, and Gowthamapura Venkatappa Kavana. "Critical evaluation of drug promotional literature using the WHO guidelines: A hospital-based, cross-sectional, and observational study." National Journal of Physiology, Pharmacy and Pharmacology 14.2 (2024), 254-258. Print. doi:10.5455/njppp.2023.13.06332202307072023

APA (American Psychological Association) Style

Chaithra, K. N., Sparshadeep, . E. M., Rajesh, . B., Priyadarshini, . B. G. & Kavana, . G. V. (2024) Critical evaluation of drug promotional literature using the WHO guidelines: A hospital-based, cross-sectional, and observational study. National Journal of Physiology, Pharmacy and Pharmacology, 14 (2), 254-258. doi:10.5455/njppp.2023.13.06332202307072023

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article